GLP-1 RA
/ˌdʒiː.elˌpiː ˈwʌn ɑːr ˈeɪ/
Also known as glucagon-like peptide-1 receptor agonist. A class of medications originally developed to treat type 2 diabetes, now also widely used for weight management. These drugs have attracted attention for their potential to reduce obesity-related health risks and possibly extend healthy lifespan.
Related content
